Xenical

Product formulated to manage obesity and intended to support weight reduction by inhibiting dietary fat absorption in the digestive tract.

Strengths: 60 · 120mg

Medicine details

Alternative names

Alli

Therapeutic class

Lipase Inhibitor

Pharmacological class

Gastrointestinal Lipase Inhibitor

Known off-label uses

type 2 diabetes mellitus

Contraindications

chronic malabsorption syndrome; cholestasis; pregnancy; breastfeeding

Minor side effects

flatulence; faecal urgency; fatty stools; abdominal pain

Moderate side effects

liquid stools; incontinence

Dosage forms

Capsule, hard

Administration route

Oral use

Prescription status

POM

Manufacturer

Cheplapharm

Onset Time

1–2 hours

Duration

variable based on meal

Storage instructions

Store below 25°C in a dry place, protected from sunlight.

Drug interactions

ciclosporin; levothyroxine; amiodarone; warfarin

Age restrictions

For adults only.

Pregnancy and breastfeeding

Pregnancy: Not recommended. Breastfeeding: Not recommended.

Precautions and warnings

maintain adequate intake of fat-soluble vitamins; may cause changes in bowel habits; maintain a balanced diet

Serious side effects

cholelithiasis — requires immediate medical attention; pancreatitis — requires immediate medical attention; hepatitis — requires immediate medical attention

Patient summary

Product formulated to manage obesity and intended to support weight reduction by inhibiting dietary fat absorption in the digestive tract.

Mechanism of action

This medicine acts as a peripheral lipase inhibitor, preventing the body from breaking down and absorbing fats from the diet, which are then eliminated through bowel movements.

Xenical

Product formulated to manage obesity and intended to support weight reduction by inhibiting dietary fat absorption in the digestive tract.

Editorial Notes

  • Active ingredient(s): Orlistat
  • Listed indication(s): Obesity, Overweight

Usually available as

  • 180 tablets - 60 mg1056-60-mg-13146
  • 84 tablets - 120 mg1056-120-mg-13150